{
    "id": "dbpedia_2482_2",
    "rank": 72,
    "data": {
        "url": "https://www.galderma.com/governance/MichaelBauer",
        "read_more_link": "",
        "language": "en",
        "title": "Michael Bauer",
        "top_image": "https://www.galderma.com//sites/default/files/Galderma_Logo.jpg",
        "meta_img": "https://www.galderma.com//sites/default/files/Galderma_Logo.jpg",
        "images": [
            "https://www.galderma.com/themes/custom/corporate_theme/logo.svg",
            "https://www.galderma.com/sites/default/files/2022-03/Instagram%20icon.jpg",
            "https://www.galderma.com/sites/default/files/2021-03/linkedin.png",
            "https://www.galderma.com/sites/default/files/2024-03/X_icon_March2024.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Michael Bauer joined EQT Partners in 2009 and is currently a partner, head of EQT's private equity Switzerland team and global co-head of EQT's healthcare sector team. Prior to joining EQT Partners, Michael worked as Investment Director at Capvis in Zurich (2003 to 2009) and in the M&A team at Credit Suisse in London (2002-2003).",
        "meta_lang": "en",
        "meta_favicon": "/themes/custom/corporate_theme/favicon.ico",
        "meta_site_name": "Galderma",
        "canonical_link": "https://www.galderma.com/governance/MichaelBauer",
        "text": "Michael Bauer joined EQT Partners in 2009 and is currently a partner, head of EQT's private equity Switzerland team and global co-head of EQT's healthcare sector team. Prior to joining EQT Partners, Michael worked as Investment Director at Capvis in Zurich (2003 to 2009) and in the M&A team at Credit Suisse in London (2002-2003).\n\nMr. Bauer currently serves on the boards of SPT Labtech via holding company Seaport Topco Limited, Viturin AG, EQT Partners AG and is a member of the advisory committee to the board of Dechra Pharmaceuticals. He holds a master's degree in business administration from the University of St. Gallen and an MBA from the University of Chicago Booth School of Business."
    }
}